149P HLA/SIRPa bispecifics: A novel multitarget therapeutic strategy to induce potent anti-tumor immune responses
Rafiei, A., Bengert, I., Kerr, L., Sigrist, J., Yang, C.L., Gualandi, M., Kumar, A., Ebersbach, H., Coats, S., Belaunzaran, O. Marroquin
Published in Immuno-oncology technology (01.12.2023)
Published in Immuno-oncology technology (01.12.2023)
Get full text
Journal Article